Author

Paige C. Arneson‐Wissink

Oregon Health & Science UniversityORCID 0000-0002-2706-9652Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:mouse· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Aaron J. GrossbergiD· 2 shared Heike Mendez· 2 shared Parham DibaiD· 2 shared Peter R. Levasseur· 2 shared Alex ChitsazaniD· 1 shared Alexandra Q. BartlettiD· 1 shared Antony JozićiD· 1 shared Beth L. WorleyiD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Aaron J. GrossbergORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Impaired adipose anabolism in pancreatic cancer cachexia is reversed by HuR inhibition

Paige C. Arneson‐Wissink, Katherine R. Pelz, Beth L. Worley, Heike Mendez, Peter T. Pham, Parham Diba, Peter R. Levasseur, Grace A. McCarthy, Alex Chitsazan, Jonathan Robert Brody, Aaron J. Grossberg

This study identifies impaired adipose anabolism in pancreatic cancer cachexia and shows that HuR inhibition restores adipose anabolism in mice.

Journal of Cachexia Sarcopenia and Muscle · Mar 19, 2026Peer-reviewedCancer Biology

Interleukin 6 drives durable T cell-mediated immunity to pancreatic cancer

Paige C. Arneson‐Wissink, Alexandra Q. Bartlett, Heike Mendez, Xinxia Zhu, Peter R. Levasseur, Parham Diba, Namratha Turuvekere Vittala Murthy, Jessica Dickie, Matthew McWhorter, Antony Jozić, Yulia Eygeris, Gaurav Sahay, Katelyn T. Byrne, Gregory David Scott, Robert L Eil, Aaron J. Grossberg

This study shows that IL-6 enhances T cell-mediated anti-tumor immunity in pancreatic cancer by increasing lymphoid aggregates, CD4 T cells, and reducing Tregs.

Cellular and Molecular Gastroenterology and Hepatology · Jan 1, 2026Peer-reviewedCancer Biology